Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,951,656
-$18,770,844 QoQ
Shares Held
50,607
-43.8% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#69
of 505 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. ARGX ranks #26 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in ARGX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,951,656 | 50,607 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $65,722,500 | 90,000 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $163,774,627 | 297,113 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $82,054,388 | 138,637 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $55,219,005 | 89,787 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $91,496,056 | 168,787 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,802,270 | 106,507 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $41,448,228 | 108,951 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $52,088,690 | 105,951 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $59,549,185 | 152,796 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $125,334,421 | 336,396 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $108,874,226 | 287,396 | Shares | Sole | 2023-02-14 | |
| 2020-12-31 | $10,293,150 | 35,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,563,000 | 25,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||